STRS Ohio’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

STRS Ohio’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,100	Closed	-$186K	–	2343
2020 Q4	$186K	Sell	8,100 -23,000	-74%	-$292K	﹤0.01%	1761
2020 Q3	$316K	Hold	31,100	–	–	﹤0.01%	1549
2020 Q2	$463K	Buy	31,100 +29,200	+1,537%	+$450K	﹤0.01%	1361
2020 Q1	$23K	Hold	1,900	–	–	﹤0.01%	1893
2019 Q4	$30K	Hold	1,900	–	–	﹤0.01%	1951
2019 Q3	$23K	Buy	+1,900	New	+$21.5K	﹤0.01%	1970

STRS Ohio's PRVL Position: Q1 2021 in Review

STRS Ohio sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 8,100 shares — an estimated $186K sold.

STRS Ohio first reported a position in PRVL in Q3 2019 and held it in 6 quarters. The position peaked at $463K in Q2 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

STRS Ohio reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
STRS Ohio sold 8,100 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $186K.
STRS Ohio first reported a position in Prevail Therapeutics Inc. Common Stock in Q3 2019 and held it in 6 quarters.
STRS Ohio's Prevail Therapeutics Inc. Common Stock position peaked at $463K in Q2 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.